Androgen mediated translational and postranslational regulation of IGFBP-2 in androgen-sensitive LNCAP human prostate cancer cells

David Degraff, Adam A. Aguiar, Qian Chen, Lisa K. Adams, B. Jill Williams, Robert A. Sikes

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The insulin-like growth factor (IGF) axis is associated intimately with prostate cancer (PCa) development, growth, survival and metastasis. In particular, increased levels of IGFBP-2 expression are associated with advanced PCa, bone metastasis, and the development of castrate resistant PCa. Previously, we reported that androgen treatment decreased intracellular and extracellular IGFBP-2 in the androgen sensitive (AS) PCa cell line, LNCaP. Nonetheless, the mechanism by which androgen treatment decreases expression of IGFBP-2 is not clear. Since elevated IGFBP-2 is associated with a variety of advanced cancers, including PCa, coupled with the fact that hormone ablation is the customary treatment modality for advanced PCa, a complete understanding of the influence of androgens on IGFBP-2 expression is essential. Androgen treatment initially increased steady state IGFBP-2 mRNA levels in LNCaP cells. Extended androgen treatment on LNCaP resulted in a time-dependent decrease in both steady state IGFBP-2 mRNA and protein. Polysomal mRNA analysis showed no difference in IGFBP-2 association with a given fraction; however, Q-PCR revealed less IGFBP-2 mRNA in each androgen-treated fraction. In addition, there was an overall decrease in polysome mRNA after androgen treatment. Extracellular proteolysis of IGFBP-2 was prevented in the presence of serine protease inhibitors. These data indicate that androgen acts via multiple levels to down-regulate IGFBP-2 in LNCaP PCa cells.

Original languageEnglish (US)
Pages (from-to)200-208
Number of pages9
JournalAmerican Journal of Translational Research
Volume2
Issue number2
StatePublished - 2010

Fingerprint

Insulin-Like Growth Factor Binding Protein 2
Androgens
Prostatic Neoplasms
Cells
Messenger RNA
Proteolysis
Neoplasm Metastasis
Bone Neoplasms
Serine Proteinase Inhibitors
Polyribosomes
Bone Development
Somatomedins
Ablation
Growth and Development
Bone
Down-Regulation

All Science Journal Classification (ASJC) codes

  • Medicine(all)
  • Molecular Medicine
  • Clinical Biochemistry
  • Cancer Research

Cite this

Degraff, David ; Aguiar, Adam A. ; Chen, Qian ; Adams, Lisa K. ; Williams, B. Jill ; Sikes, Robert A. / Androgen mediated translational and postranslational regulation of IGFBP-2 in androgen-sensitive LNCAP human prostate cancer cells. In: American Journal of Translational Research. 2010 ; Vol. 2, No. 2. pp. 200-208.
@article{0203d1dfc12840059537554ac174783f,
title = "Androgen mediated translational and postranslational regulation of IGFBP-2 in androgen-sensitive LNCAP human prostate cancer cells",
abstract = "The insulin-like growth factor (IGF) axis is associated intimately with prostate cancer (PCa) development, growth, survival and metastasis. In particular, increased levels of IGFBP-2 expression are associated with advanced PCa, bone metastasis, and the development of castrate resistant PCa. Previously, we reported that androgen treatment decreased intracellular and extracellular IGFBP-2 in the androgen sensitive (AS) PCa cell line, LNCaP. Nonetheless, the mechanism by which androgen treatment decreases expression of IGFBP-2 is not clear. Since elevated IGFBP-2 is associated with a variety of advanced cancers, including PCa, coupled with the fact that hormone ablation is the customary treatment modality for advanced PCa, a complete understanding of the influence of androgens on IGFBP-2 expression is essential. Androgen treatment initially increased steady state IGFBP-2 mRNA levels in LNCaP cells. Extended androgen treatment on LNCaP resulted in a time-dependent decrease in both steady state IGFBP-2 mRNA and protein. Polysomal mRNA analysis showed no difference in IGFBP-2 association with a given fraction; however, Q-PCR revealed less IGFBP-2 mRNA in each androgen-treated fraction. In addition, there was an overall decrease in polysome mRNA after androgen treatment. Extracellular proteolysis of IGFBP-2 was prevented in the presence of serine protease inhibitors. These data indicate that androgen acts via multiple levels to down-regulate IGFBP-2 in LNCaP PCa cells.",
author = "David Degraff and Aguiar, {Adam A.} and Qian Chen and Adams, {Lisa K.} and Williams, {B. Jill} and Sikes, {Robert A.}",
year = "2010",
language = "English (US)",
volume = "2",
pages = "200--208",
journal = "American Journal of Translational Research",
issn = "1943-8141",
publisher = "e-Century Publishing Corporation",
number = "2",

}

Androgen mediated translational and postranslational regulation of IGFBP-2 in androgen-sensitive LNCAP human prostate cancer cells. / Degraff, David; Aguiar, Adam A.; Chen, Qian; Adams, Lisa K.; Williams, B. Jill; Sikes, Robert A.

In: American Journal of Translational Research, Vol. 2, No. 2, 2010, p. 200-208.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Androgen mediated translational and postranslational regulation of IGFBP-2 in androgen-sensitive LNCAP human prostate cancer cells

AU - Degraff, David

AU - Aguiar, Adam A.

AU - Chen, Qian

AU - Adams, Lisa K.

AU - Williams, B. Jill

AU - Sikes, Robert A.

PY - 2010

Y1 - 2010

N2 - The insulin-like growth factor (IGF) axis is associated intimately with prostate cancer (PCa) development, growth, survival and metastasis. In particular, increased levels of IGFBP-2 expression are associated with advanced PCa, bone metastasis, and the development of castrate resistant PCa. Previously, we reported that androgen treatment decreased intracellular and extracellular IGFBP-2 in the androgen sensitive (AS) PCa cell line, LNCaP. Nonetheless, the mechanism by which androgen treatment decreases expression of IGFBP-2 is not clear. Since elevated IGFBP-2 is associated with a variety of advanced cancers, including PCa, coupled with the fact that hormone ablation is the customary treatment modality for advanced PCa, a complete understanding of the influence of androgens on IGFBP-2 expression is essential. Androgen treatment initially increased steady state IGFBP-2 mRNA levels in LNCaP cells. Extended androgen treatment on LNCaP resulted in a time-dependent decrease in both steady state IGFBP-2 mRNA and protein. Polysomal mRNA analysis showed no difference in IGFBP-2 association with a given fraction; however, Q-PCR revealed less IGFBP-2 mRNA in each androgen-treated fraction. In addition, there was an overall decrease in polysome mRNA after androgen treatment. Extracellular proteolysis of IGFBP-2 was prevented in the presence of serine protease inhibitors. These data indicate that androgen acts via multiple levels to down-regulate IGFBP-2 in LNCaP PCa cells.

AB - The insulin-like growth factor (IGF) axis is associated intimately with prostate cancer (PCa) development, growth, survival and metastasis. In particular, increased levels of IGFBP-2 expression are associated with advanced PCa, bone metastasis, and the development of castrate resistant PCa. Previously, we reported that androgen treatment decreased intracellular and extracellular IGFBP-2 in the androgen sensitive (AS) PCa cell line, LNCaP. Nonetheless, the mechanism by which androgen treatment decreases expression of IGFBP-2 is not clear. Since elevated IGFBP-2 is associated with a variety of advanced cancers, including PCa, coupled with the fact that hormone ablation is the customary treatment modality for advanced PCa, a complete understanding of the influence of androgens on IGFBP-2 expression is essential. Androgen treatment initially increased steady state IGFBP-2 mRNA levels in LNCaP cells. Extended androgen treatment on LNCaP resulted in a time-dependent decrease in both steady state IGFBP-2 mRNA and protein. Polysomal mRNA analysis showed no difference in IGFBP-2 association with a given fraction; however, Q-PCR revealed less IGFBP-2 mRNA in each androgen-treated fraction. In addition, there was an overall decrease in polysome mRNA after androgen treatment. Extracellular proteolysis of IGFBP-2 was prevented in the presence of serine protease inhibitors. These data indicate that androgen acts via multiple levels to down-regulate IGFBP-2 in LNCaP PCa cells.

UR - http://www.scopus.com/inward/record.url?scp=77953414581&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953414581&partnerID=8YFLogxK

M3 - Article

C2 - 20407609

AN - SCOPUS:77953414581

VL - 2

SP - 200

EP - 208

JO - American Journal of Translational Research

JF - American Journal of Translational Research

SN - 1943-8141

IS - 2

ER -